[1] 张月明. 新疆食管癌的分布[J]. 新疆医学院学报,1988 11(2):139-144. [2] Varnholt H. The role of microRNAs in primary liver cancer[J]. Ann Hepatol,2008,7(2):104-113. [3] 李秀梅,陈 艳,王洪江,等. 哈萨克族食管癌中MMP-1、MMP-2、MMP-7、TIMP-1和MTA1的表达及其临床病理意义[J]. 癌变·畸变·突变,2011,23(3):190-198. [4] Nehad MA,Michelle L,Emma I,et al. miR-218 suppresses nasopharyngeal cancer progression through down regulation of survivin and the SLIT2-ROBO1 pathway[J]. Cancer Res 2011,71(6):381-2391. [5] Ozen M,Creighton CJ,Ozdemir M. Wide spread deregulation of microRNA expression in human prostate cancer[J]. Oncogene,2008,27(12):1788-1793. [6] Chen X,Guo X,Zhang H. Role of miR-143 targeting KRAS in colorectal tumorigenesis[J]. Oncogene,2009,28(10):1385-1392. [7] 李鹏超,陶 俊,吕 强,等. MiR-143在膀胱移行细胞癌中的表达和功能[J]. 南京医科大学学报:自然科学版,2010,30(9):1235-1239. [8] Takagi T,Iio A,Nakagawa Y. Decreased expression of microRNA-143 and-145 in human gastric cancers[J]. Oncology 2009,77(1):12-21. [9] 王 勇,孙跃明. microRNA143、microRNA145对胆管癌细胞株 QBC939生长周期及凋亡的影响[J]. 南京医科大学学报,2010,30(5):612-616. [10] REN Ye,GUO Fengjing,CHEN Anmin,et al. Involvement of MMP-2 in adriamycin resistance dependent on ERK1/2 signal pathway in human osteosarcoma MG-63 cells[J]. J Huazhong U Sci-Med,2012,32(1):82-86. [11] 朱慧芳,左学军,雷 鸣,等. MMP-2、TIMP-2和CD44V6 基因蛋白在卵巢浆液性肿瘤中的表达及临床意义[J]. 中国妇幼保健医院,2011,2(22):3470-3472. [12] Jung YS,Liu XW,Chirco R,et al. TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain[J]. PLoS One,2012,7(6):38773- 38779. [13] Wang Yunyan,Meng Junsong,Zhuang Haijun,et al. Expressions and clinical significances of MMP-2 and TIMP-2 mRNA in bladder transitional cell carcinomas[J]. Chin Germ J Clin Oncol,2011,10(5):278-281. |